the aid library

LIST OPTIONS

Filter

4525

COVID-19 in the Americas: Listening to the most vulnerable - Community perceptions from migrants, refugees, host communities and indigenous populations

The International Federation of Red Cross and Red Crescent Societies IFRC (2022) CC

This research report offers community perceptions of COVID-19 from migrants, refugees, host communities and indigenous populations in nine countries in the Americas: Argentina, Brazil, Bolivia, Colombia, Guatemala, Nicaragua, Jamaica, Panama and Trinidad and Tobago. It reveals the myriad impacts ... more

Download (415)

View PDF (794)

Yemen: The World’s Worst Humanitarian Crisis Enters Another Year

Andrea Carboni Armed Conflict Location and Events Dataset (2018) C1

Four years after the Houthi takeover of the capital Sana’a and the beginning of the Saudi-led military intervention, there is little to suggest that Yemen will find peace in the near future. As of January 2018, the conflict has killed tens of thousands of people and displaced millions, causing wid... more

Download (588)

View PDF (945)

Running the Ebola Response: The Triple Helix of Information, Logistics and Coordination

The Disaster Resilience Lab (2014)

Preliminary Key Findings from Interviews in Accra on the Ebola Response

Download (437)

View PDF (462)

Youth-centred digital health digital health interventions

World Health Organization WHO (2020) C_WHO

A framework for planning, developing and implementing solutions with and for young people. The guidance presented in this document is intended for digital health intervention designers, developers, implementers, researchers and funders. Newcomers to digital health can use it as a start-to-finish pr... more

Download (477)

View PDF (690)

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

World Health Organization WHO (2023) CC

Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected. Infection prevention and control (IP... more

Download (708)

View PDF (1477)

Zika Strategic Response Plan Quarterly update, October 2016

World Health Organization WHO (2016) C_WHO

Download (275)

View PDF (322)

Longlist of knowledge gaps in Planetary health

Royal Netherlands Academy of Arts and Sciences (2023) C2

The longlist of knowledge gaps is based on existing research agendas published in 2015 or later and expert input from reviewers of the first draft of the longlist. It only includes knowledge gaps focussing on a better understanding of the relationship between global environmental change and human h... more

Download (562)

View PDF (630)

Клиническое ведение тяжелой острой респираторной инфекции: методическое пособие. Версия, адаптированная для борьбы с COVID-19
recommended

World Health Organization WHO (2020) C_WHO

Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation

External Link

TACKLING ANTIMICROBIAL RESISTANCE (AMR) TOGETHER Working Paper 5.0: Enhancing the focus on gender and equity

World Health Organization WHO (2018) C_WHO

This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e... more

Download (245)

View PDF (368)

Solidarity in response to the COVID-19 pandemic

Rahman-Shepherd, A.; C. Clift; E. Ross; et al. The Chatham House (2021) CC

Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec... more

Download (447)

View PDF (679)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (859)

View PDF (1347)

Handbook for Emergencies

UNHCR (2007) C2

Section One summarizes UNHCR’s mandate of international protecdtion and the aim and principles of emergency response; Section Two deals with emergency management; Section Three covers the vital sectors and problem areas in refugee emergencies, including health, food, sanitation and water, a... more

Download (1394)

View PDF (977)

WHO recommendations on antenatal care for a positive pregnancy experience. Russian Version

World Health Organization WHO (2016) C_WHO

Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности

Download (290)

View PDF (572)

Report from the scoping consultation on severe bacterial infections among people with advanced HIV disease

World Health Organization WHO (2022) CC

Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re... more

Download (1080)

View PDF (1507)

Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended

World Health Organization (WHO) (2022) C_WHO

Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi... more

Download (1148)

View PDF (1398)

Linee guida dell’OMS sul trattamento farmacologico del dolore persistente nei bambini con patologie croniche gravi

World Health Organization Fondazione IRCCS, Istituto Nazionale dei Tumori (2014) C_WHO

External Link

Disruption in essential health services in Mexico during COVID-19: an interrupted time series analysis of health information system data

Doubova SV, Leslie HH, Kruk ME, et al. BMJ Global Health (2021) CC

INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and outcomes in Mexico, describe observed and predicted trends in services over 24 months, and to estimat... more

Download (182)

View PDF (169)

Operational handbook on tuberculosis: module 6: tuberculosis and co-morbidities, 3rd ed

World Health Organization WHO (2025) C_WHO

Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base... more

Download (251)

View PDF (395)

COVID-19 and political stability in Ethiopia

Yusuf S. Institute for security Studies (2020) C1

This policy brief examines the implications of COVID-19 and the government’s preventative measure for political stability,9 especially in the short to medium term. It argues that in the short term the disease and the preventative measures could make the country less vulnerable to organised politic... more

Download (377)

View PDF (638)

Global tuberculosis report 2022
recommended

World Health Organization WHO (2022) C_WHO

The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets. ... more

Infection prevention and control guideline for Ebola and Marburg disease, August 2023 recommended

Клиническое ведение тяжелой острой респираторной инфекции: методическое пособие. Версия, адаптированная для борьбы с COVID-19 recommended

Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda recommended

Global tuberculosis report 2022 recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

Клиническое ведение тяжелой острой респираторной инфекции: методическое пособие. Версия, адаптированная для борьбы с COVID-19
recommended

Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended

Global tuberculosis report 2022
recommended